Roche launches new analyzer for HbA1c testing

• Roche (OTCQX:RHHBY) launches its new CE-Mark'd high throughput analyzer for HbA1c testing for diabetics, the cobas c 513, which replaces its existing analyzer, the COBAS INTEGRA 800 CTS. The c 513 can process up to 400 patient results per hour, twice the throughput of INTEGRA.
• The c 513 also features direct results reporting and higher on-board test capacity (the lab can load more tests at a time).